The Human Genome Project has changed total technological basis of science. There is a paradigm shift in the way bioresearch is conducted. Indian industries should think how to apply biological knowledge in the changed scenario. He said that the industry would also have to bear the responsibility of higher education in the field of genomics. India, he said, has a strategic advantage as it has one-fifth of the world s genetic population.
Genome informatics is one area that every information company wants to get into.
Software tools for functional genomics have been developed. He said there was immense business possibility in the creation of adverse drug reaction database. There is a need for intellectual property rights-protected international collaboration and knowledge partnership to provide better and affordable healthcare for the people of India.